Unilever

ULNYSEUSD

THESIS ALERT

Email me when the UL thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$65.78
−$0.69 (−1.04%)Today 1M +6.76%
After hours$65.780.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$66.47
Prior regular-session close from the quote source.
$65.42–$66.07
Regular-session low and high so far today.
3.9M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$54.75–$74.98
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own UL if Unilever converts global brand scale, pricing power and repeat consumer demand into consistent cash flow and margin resilience; the stock depends on management turning that cash into sustained organic growth or shareholder returns.

UL price history

Latest price$65.78Today−$0.69 (-1.04%)
UL +4.75%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Unilever's brand pricing power and cost-management will sustain operating income and operating-margin resilience even if headline revenue stays flat or declines.StrengtheningMateriality: High

    Operating income has been roughly stable: 8,998,000,000 EUR (2023), 8,829,000,000 EUR (2024) and 9,037,000,000 EUR (2025) despite revenue weakness. If true, shareholders get stable cash flow and the company can buy back shares/dividend without needing top-line growth; if false, profits and returns will fall quickly.

    Watch: Sustained acceleration of private-label share gains or major retailer delistings in key categories (e.g., loss of distribution in Home Care).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating income has been roughly stable: 8,998,000,000 EUR (2023), 8,829,000,000 EUR (2024) and 9,037,000,000 EUR (2025) despite revenue weakness.

    Open source ↗
  • Consistent operating cash flow and a multi-billion euro cash balance give management flexibility to fund dividends, buybacks and selective M&A without stressing the core business.HoldingMateriality: High

    Operating cash flow was 7,282,000,000 EUR (2022), rose to 9,519,000,000 EUR (2024) and was 8,350,000,000 EUR (2025). If cash generation holds, shareholders get predictable returns and corporate optionality; if cash weakens, dividends/buybacks or M&A will be constrained or require leverage.

    Watch: A sudden working-capital shock or materially higher capex requirements (e.g., large factory rebuilds) that reduce free cash flow.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating cash flow was 7,282,000,000 EUR (2022), rose to 9,519,000,000 EUR (2024) and was 8,350,000,000 EUR (2025).

    Open source ↗
  • The sharp rise in diluted EPS in 2025 reflects improved net income and must be sustained by recurring operating performance (not one‑off gains or transient FX); otherwise EPS will revert.HoldingMateriality: Medium

    Diluted EPS rose from 2.58 EUR (2024) to 4.32 EUR (2025). Sustained EPS growth underpins valuation upside; if the 2025 EPS jump proves temporary, expected returns will be weaker than they appear.

    Watch: If the 2025 net income gain is driven by one-off items (asset disposals, tax adjustments) or favourable FX that reverse in subsequent periods.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Diluted EPS rose from 2.58 EUR (2024) to 4.32 EUR (2025).

    Open source ↗
  • Top-line growth is the weak link: absent a clear recovery in organic sales or market-share gains, Unilever’s revenue will remain pressured by category cyclicality and private-label competition.WeakeningMateriality: Medium

    Revenue declined from 60,073,000,000 EUR (2022) to 50,503,000,000 EUR (2025) with 2023–2025 at a lower run-rate than 2022. If revenue cannot be restored, any EPS gains must come from margin squeezes or financial engineering, which are less durable and limit upside; if revenue recovers, valuation multiple expansion becomes plausible.

    Watch: Sustained consumer downtrading to private labels or discount channels reducing Unilever’s share in key categories.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Revenue declined from 60,073,000,000 EUR (2022) to 50,503,000,000 EUR (2025) with 2023–2025 at a lower run-rate than 2022.

    Open source ↗
  • Gross-margin defense (through pricing, formula/pack mix and supply-chain actions) is a leading indicator of whether profits are durable; sustained declines in gross_profit relative to revenue would show loss of pass-through.StrengtheningMateriality: Medium

    Gross profit figures have remained in a similar band: 24,167,000,000 EUR (2022), 22,500,000,000 EUR (2023), 24,503,000,000 EUR (2024), 23,709,000,000 EUR (2025). Gross-margin weakness would presage operating-margin compression and reduced cash flow, while steady gross_profit implies the company can manage input-cost swings.

    Watch: Rapid or persistent commodity-cost inflation (e.g., oils, packaging) that management cannot pass to consumers.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Gross profit figures have remained in a similar band: 24,167,000,000 EUR (2022), 22,500,000,000 EUR (2023), 24,503,000,000 EUR (2024), 23,709,000,000 EUR.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Unilever's brand pricing power and cost-management will sustain operating income and operating-margin resilience even if headline revenue stays flat or declines. If true, shareholders get stable cash flow and the company can buy back shares/dividend without needing top-line growth; if false, profits and returns will fall quickly.

Consistent operating cash flow and a multi-billion euro cash balance give management flexibility to fund dividends, buybacks and selective M&A without stressing the core business. If cash generation holds, shareholders get predictable returns and corporate optionality; if cash weakens, dividends/buybacks or M&A will be constrained or require leverage.

The sharp rise in diluted EPS in 2025 reflects improved net income and must be sustained by recurring operating performance (not one‑off gains or transient FX); otherwise EPS will revert. Sustained EPS growth underpins valuation upside; if the 2025 EPS jump proves temporary, expected returns will be weaker than they appear.

Top-line growth is the weak link: absent a clear recovery in organic sales or market-share gains, Unilever’s revenue will remain pressured by category cyclicality and private-label competition. If revenue cannot be restored, any EPS gains must come from margin squeezes or financial engineering, which are less durable and limit upside; if revenue recovers, valuation multiple expansion becomes plausible.

Gross-margin defense (through pricing, formula/pack mix and supply-chain actions) is a leading indicator of whether profits are durable; sustained declines in gross_profit relative to revenue would show loss of pass-through. Gross-margin weakness would presage operating-margin compression and reduced cash flow, while steady gross_profit implies the company can manage input-cost swings.

All standing thesis claims
Original report summary

Unilever converts global brand scale, pricing power and repeat consumer demand into consistent cash flow and margin resilience; the stock depends on management turning that cash into sustained organic growth or shareholder returns.

Evidence assessed Oct 15, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Unilever

Where the evidence on Unilever disagrees: Mixed on the latest evidence (Oct 15, 2026). Of its 5 thesis points, 2 strengthening, 2 holding and 1 weakening.

Bull case: what the evidence supports

  • Unilever's brand pricing power and cost-management will sustain operating income and operating-margin resilience even if headline revenue stays flat or declines.

    sec.gov ↗

  • Consistent operating cash flow and a multi-billion euro cash balance give management flexibility to fund dividends, buybacks and selective M&A without stressing the core business.

    sec.gov ↗

  • The sharp rise in diluted EPS in 2025 reflects improved net income and must be sustained by recurring operating performance (not one‑off gains or transient FX); otherwise EPS will revert.

    sec.gov ↗

  • Gross-margin defense (through pricing, formula/pack mix and supply-chain actions) is a leading indicator of whether profits are durable; sustained declines in gross_profit relative to revenue would show loss of pass-through.

    sec.gov ↗

Bear case: what the evidence questions

  • Top-line growth is the weak link: absent a clear recovery in organic sales or market-share gains, Unilever’s revenue will remain pressured by category cyclicality and private-label competition.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Unilever

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

Loading the break-condition record for Unilever.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    DIRECTOR/PDMR SHAREHOLDING.

    Unilever filed an SEC report on 2026-09-25: DIRECTOR/PDMR SHAREHOLDING. It is a dated development that tests the current thesis.

  2. Mixed
    DIRECTOR/PDMR SHAREHOLDING.

    Unilever filed an SEC report on 2026-09-24: DIRECTOR/PDMR SHAREHOLDING. It is a dated development that tests the current thesis.

  3. Mixed
    TOTAL VOTING RIGHTS.

    Unilever filed an SEC report on 2026-09-01: TOTAL VOTING RIGHTS. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Sustained acceleration of private-label share gains or major retailer delistings in key categories (e.g., loss of distribution in Home Care).
  • A sudden working-capital shock or materially higher capex requirements (e.g., large factory rebuilds) that reduce free cash flow.
  • If the 2025 net income gain is driven by one-off items (asset disposals, tax adjustments) or favourable FX that reverse in subsequent periods.
  • Sustained consumer downtrading to private labels or discount channels reducing Unilever’s share in key categories.
  • Rapid or persistent commodity-cost inflation (e.g., oils, packaging) that management cannot pass to consumers.

UL news

Loading headlines…

Financial statements

UL income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

UL: quick answers

What is UL's short interest?
As of October 30, 2026, 5.8M UL shares were sold short, up 30.9% from the count before. At the stock's average daily volume that is 1.2 days to cover. FINRA publishes the count twice a month. UL short interest history
Have members of Congress traded UL?
70 trades in UL have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed UL trade
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.